A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy.

@article{Fung1999ARO,
  title={A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy.},
  author={Man Chung Fung and Anna Maria Storniolo and Bichlien Nguyen and Michael B Arning and W Brookfield and Janet Vigil},
  journal={Cancer},
  year={1999},
  volume={85 9},
  pages={2023-32}
}
BACKGROUND Hemolytic uremic syndrome (HUS) is a rare condition that occasionally is reported in cancer patients. Recently it has been observed that gemcitabine rarely may be associated with this condition. METHODS The manufacturer's safety database and literature were reviewed for any report regarding gemcitabine associated with renal and hematologic… CONTINUE READING